Recovery from severe ischemic cardiomyopathy after high-risk percutaneous coronary intervention facilitated by levosimendan infusion and Impella CP support and prolonged use of a wearable defibrillator vest.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Floating echo in the inlet area of Impella CP device during high-risk percutaneous coronary intervention: how to extract the device?Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2026
   Article
2. Dissection of epigastric artery after percutaneous coronary intervention with Impella CP device.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2025
   Article
3. How to unfold a folded large-bore sheath after Impella-supported percutaneous coronary intervention.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2025
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.